[HTML][HTML] Role of cardiac biomarkers in cancer patients

GC Semeraro, CM Cipolla, DM Cardinale - Cancers, 2021 - mdpi.com
Simple Summary Cardiac biomarkers have proved increasingly useful in the various
branches of cardiology, not sparing the field of cardio-oncology. With specific reference to …

[HTML][HTML] Cardiac biomarkers for the detection and management of cancer therapy-related cardiovascular toxicity

X Zhang, Y Sun, Y Zhang, F Fang, J Liu, Y Xia… - Journal of …, 2022 - mdpi.com
Cardiotoxicity is one of the major side effects of anti-cancer therapy affecting the overall
prognosis of patients and possibly leading to the discontinuation of chemotherapy …

Cardiac structure, function, and coronary anatomy 10 years after isolated contemporary adjuvant radiotherapy in breast cancer patients with low cardiovascular …

P Krug, X Geets, M Berlière, F Duhoux… - European Heart …, 2024 - academic.oup.com
Aims The effects of isolated contemporary low-dose breast cancer (BC) radiotherapy (RT) on
the heart remain poorly understood. This study aims to assess the long-term impacts of BC …

Implementation of volumetric-modulated arc therapy for locally advanced breast cancer patients: Dosimetric comparison with deliverability consideration of planning …

C Noblet, M Duthy, F Coste, M Saliou, B Samain… - Physica Medica, 2022 - Elsevier
Purpose The aim of this study was to implement a clinically deliverable VMAT planning
technique dedicated to advanced breast cancer, and to predict failed QA using a machine …

[HTML][HTML] The role of advanced cardiovascular imaging modalities in cardio-oncology: from early detection to unravelling mechanisms of cardiotoxicity

I Leo, M Vidula, G Bisaccia, MC Procopio… - Journal of Clinical …, 2023 - mdpi.com
Advances in cancer therapies have led to a global improvement in patient survival rates.
Nevertheless, the price to pay is a concomitant increase in cardiovascular (CV) morbidity …

[PDF][PDF] Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology

JA Gambril, A Chum, A Goyal, P Ruz, K Mikrut… - Heart failure clinics, 2022 - Elsevier
● Synopsis (100 words or less): Cardiovascular (CV) events are an increasingly common
limitation of effective anticancer therapy. Over the last decade imaging has become …

[HTML][HTML] Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study

K Chufal, I Ahmad, A Prakash, A Miller, P Umesh… - Cardio-Oncology, 2024 - Springer
Objectives To investigate the association between radiotherapy (RT) and cardiac
biomarkers in women with left-sided breast cancer. Methods This prospective observational …

[HTML][HTML] Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy

CC Hsieh, CC Yu, CH Chu, WC Chen… - American Journal of …, 2023 - ncbi.nlm.nih.gov
This study aimed to investigate the dose parameters and incidence of radiotherapy (RT)-
associated toxicity in patients with left breast cancer (LBC) treated with proton-RT, compared …

[HTML][HTML] Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors

JC Heemelaar, ADG Krol, M Louwerens… - IJC Heart & …, 2021 - Elsevier
Background Thoracic irradiation is one of the cornerstones of Hodgkin lymphoma (HL)
treatment, which contributes to high rates of long-term survivorship, but begets a life-long …

[HTML][HTML] Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO …

T Gąsior, B Zaborska, P Stachowiak… - Journal of Clinical …, 2024 - mdpi.com
Background: Oncological treatment of breast cancer may be associated with adverse effects
on myocardial function. Objectives: The objective of this study was to compare the influence …